Systematic Review
Published on 27 Nov 2024
Ubiquitin-specific peptidases in lymphoma: a path to novel therapeutics
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1356634
- 1,201 views
Type at least 3 characters
2,799 articles
Editorial
Published on 27 Nov 2024
Editorial: Utilizing omics strategies to discover new drug targets for cancers
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1526976
- 615 views
Original Research
Published on 27 Nov 2024
Anti-tumor and anti-metastatic effects of RRx-001 on hepatocellular carcinoma: mechanisms of action and therapeutic potential
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1469825
- 1,135 views
Editorial
Published on 26 Nov 2024
Editorial: Exploring immunotherapy targets and strategies for cancer: a multi-omics perspective
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1506444
- 462 views
Original Research
Published on 26 Nov 2024
Role of anoikis-related gene RAC3 in prognosis, immune microenvironment, and contribution to malignant behavior in vitro and in vivo of bladder urothelial carcinoma
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1503623
- 862 views
Original Research
Published on 25 Nov 2024
Bufonis venenum extract loaded novel cholesterol-free liposome for the treatment of hepatocellular carcinoma
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1486742
- 894 views
Systematic Review
Published on 21 Nov 2024
Efficacy and safety of anti-angiogenic drugs combined with chemotherapy in the treatment of platinum-sensitive/resistant ovarian cancer: a meta-analysis with trial sequential analysis of randomized controlled trials
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1446403
- 1,054 views
Original Research
Published on 21 Nov 2024
The role of epigenetic regulation in pancreatic ductal adenocarcinoma progression and drug response: an integrative genomic and pharmacological prognostic prediction model
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1498031
- 1,851 views
Original Research
Published on 19 Nov 2024
Targeting autophagy: polydatin’s role in inducing cell death in AML
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1470217
- 944 views
- 3 citations
Original Research
Published on 19 Nov 2024
Impact of camel milk lactoferrin peptides against breast cancer cells: in silico and in vitro study
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1425504
- 1,779 views
- 1 citation
Methods
Published on 18 Nov 2024
Protocol of REACH-01: a single-arm, open label, prospective study of HAIC sequential TAE combined with tislelizumab and surufatinib in unresectable intrahepatic cholangiocarcinoma
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1435639
- 1,720 views
Original Research
Published on 18 Nov 2024
Maslinic acid induces autophagy and ferroptosis via transcriptomic and metabolomic reprogramming in prostate cancer cells
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1453447
- 1,936 views
Correction
Published on 14 Nov 2024
Corrigendum: Myricetin suppresses TGF-β-induced epithelial-to-mesenchymal transition in ovarian cancer
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1447095
- 583 views
Original Research
Published on 13 Nov 2024
Integrated analysis of single-cell and bulk transcriptome reveals hypoxia-induced immunosuppressive microenvironment to predict immunotherapy response in high-grade serous ovarian cancer
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1450751
- 1,903 views
- 1 citation
Review
Published on 13 Nov 2024
Natural products: promising therapeutics for targeting regulatory immune cells in the tumor microenvironment
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1481850
- 1,385 views
Original Research
Published on 13 Nov 2024
Mechanism of Apigenin against breast cancer stem cells: network pharmacology and experimental validation
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1496664
- 1,443 views